Russian scientists from Lebedev Physical Institute of the Russian Academy of Sciences, National Research Nuclear University MEPhI, G.G. Devyatykh Institute of Chemistry of High-Purity Substances of the Russian Academy, together ...
Emerging single-cell diagnostics rely on the potential to rapidly and efficiently isolate bacteria from complex biological matrices. In a recent study now published in Microsystems and Nanoengineering, Jung Y. Han and colleagues ...
Cancer kills more than half a million men, women, and children each year in the U.S, and chemotherapy is only slightly more discriminating than the disease it treats. As a result, many cancer treatments kill cells throughout ...
Engineered T cell immunotherapy, such as chimeric antigen receptor T cell (CAR-T) and T cell receptor T cell (TCR-T) therapy, has emerged as a potent therapeutic strategy for treating tumors.
A team of researchers from New York University has engineered nanoscale protein micelles capable of both delivering chemotherapeutic drugs and of being tracked by magnetic resonance imaging (MRI).
Nanoparticles can be used as substrates for computation, with algorithmic and autonomous control of their unique properties. However, scalable architecture to form nanoparticle-based computing systems is lacking at present. ...
Russian researchers announced the development of a combined action drug based on ionizing radiation and bacterial toxin. Their combined effect appeared to be 2,200 times stronger compared to that exerted by the radiation ...
Nanosystems that deliver anticancer drugs or imaging materials to tumours are showing significant progress, particularly those that respond to tumour-related stimuli, according to a review published in the journal Science ...
Antibody-based imaging of a particularly aggressive form of breast cancer is undergoing clinical trials worldwide, but the path from trial to application is being hampered by a major obstacle: safety.
Rice University nanoscientists have demonstrated a method for loading iron inside nanoparticles to create MRI contrast agents that outperform gadolinium chelates, the mainstay contrast agent that is facing increased scrutiny ...
